CNTA — Centessa Pharmaceuticals plc stock price, charts and financials

QT62Centessa Pharmaceuticals plc

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
40.50
+0.00%
OverviewShort InterestFilings
CNTAQT62Centessa Pharmaceuticals plc·NASDAQ
40.50+0.00%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 06, 202615-12G15-12G
Jun 26, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jun 24, 2026S-8 POSS-8 POS
Jun 24, 2026S-8 POSS-8 POS
Jun 24, 2026S-8 POSS-8 POS
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 2026S-8 POSS-8 POS
Jun 24, 2026S-8 POSS-8 POS
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 202625-NSENotification of removal from listing
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 2026SC 13DBeneficial ownership statement (active)
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 2026S-8 POSS-8 POS
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
#1 / 25 of 531
Page
▼
/ 22